IN2PHARMA
Board
4 directors, 1 in day-to-day management, no change since April 2026Director
since 02-04-2026
6-year term from 2026
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 22-06-2026
Director
since 02-04-2026
6-year term from 2026
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 22-06-2026
Director
since 02-04-2026
6-year term from 2026
listed in the 2025 annual accounts, filed on 22-06-2026
Director, permanent representative
current term since 13-04-2026
listed in the 2025 annual accounts, filed on 22-06-2026
Day-to-day manager, permanent representative
appointed by deed of 13-05-2026
term without a fixed end
earlier director, from 01-02-2021 to 02-04-2026
earlier managing director, from 30-06-2017 to 02-04-2026
also on the board of 3 other companies
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointly, or a managing director alonedeed of 13-05-2026
Permanent representatives 2
Mandates through the years
5 names, the dashed line is todayDirector
Director
Director
Director
Day-to-day manager
LeadershipBoardEarlierRest of the termmandate already running before its first mention
Mandates as a list
-
- Director, appointed by deed of 20-04-2015, still in office
-
- Director, since before 31-12-2025
-
- Director, since before 31-12-2025
-
- Director, since before 31-12-2025
-
- Managing director, appointed by deed of 23-10-2017, until 19-06-2024
- Director, until 30-06-2017
- Managing director, appointed by deed of 23-10-2017, until 02-04-2026
- Day-to-day manager, appointed by deed of 13-05-2026, still in office
With Starter you also see 5 former office holders in the mandate history.
See the plans →
Control
100%
This company
IN2PHARMA
Equity €69,300
Profit €909,969 in 2025
Capital
- Capital
- €63,000
- Shares
- 63,000
- Contribution per share
- €1
- Equity per share
- €1.10 in 2025
- Source
- deed of 19-06-2024
Owners through the years
as the annual accounts name themSource: lists of holdings in the owners' accounts
Articles of association
deed of 19-06-2024 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 19:00
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- Alle actiefbestanddelen gerealiseerd tenzij anders beslist, artikelen 2:87 en 2:88,algemene vergadering kan beperken
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 13-05-2026 ↗
- all shares
Stated in the deed
deed of 12-02-2026 ↗
- all shares
Capital over time
- 19-06-2024 Capital stated in the deed · €63,000 · 63,000 shares